Daniel R. Mudra is the Executive Director and Head of Clinical Program Management at ExploR&D, a position they have held since 2022. Previously, they served as a Senior Director at Eli Lilly and Company and contributed as a Research Scientist at XenoTech, LLC from 1997 to 2003. Daniel obtained a PhD in Pharmaceutical Chemistry from the University of Kansas in 2007, following a Master of Science in Biology from Loyola University Chicago and a Bachelor of Science in Biology from the University of Dayton.
This person is not in any teams
This person is not in any offices